For instance, BCAFs derived from HER2 positive BC have been found to enhance T47D cell migration (low migratory BC cell line) better, compared to BCAFs isolated from either ER-positive or triple-negative BCs [44]. This evidence concerns the gene ERBB2 and breast cancer.